Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Novel casein kinase 1 inhibitors claimed by sanofi-aventis for the treatment of sleep disorders

April 23, 2009

New gamma secretase inhibitors in early development at EnVivo Pharmaceuticals for AD

April 23, 2009

QRxPharma successfully completes phase III pilot study of MoxDuo IR

April 22, 2009

Taisho presents novel heterocyclic compounds for the treatment of pain

April 22, 2009

Alkylsulfone derivatives claimed by Daiichi Sankyo for the treatment of Alzheimer's disease

April 22, 2009

Psylin Neurosciences begins development of PSN-004 for depression

April 21, 2009

Phytopharm initiates safety and tolerability study of PYM-50028 in PD

April 21, 2009

Forest and Cypress launch Savella for fibromyalgia

April 21, 2009

Impax provides clinical update on IPX-066 and IPX-056

April 21, 2009

Cannabinoid CB2 modulators claimed by Kalypsys as analgesics

April 21, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...